Jump to content

Talk:MAGEA4

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

Recently a CAR-T cell therapy (TECELRA, Adaptimmune LLC) targeting MAGE-A4 protein expressed by synovial sarcoma has received approval by the FDA.

[edit]

Recently a CAR-T cell therapy (TECELRA, Adaptimmune LLC) targeting MAGE-A4 protein expressed by synovial sarcoma has received approval by the FDA.

Source 155.105.80.104 (talk) 07:00, 21 August 2024 (UTC)[reply]